Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Other Operating Expenses (2016 - 2017)

IGC Pharma (IGC) has disclosed Other Operating Expenses for 4 consecutive years, with -$757260.0 as the latest value for Q1 2017.

  • Quarterly Other Operating Expenses rose 32.34% to -$757260.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was -$757260.0 through Dec 2017, up 66.03% year-over-year, with the annual reading at -$1.9 million for FY2017, 33.51% up from the prior year.
  • Other Operating Expenses for Q1 2017 was -$757260.0 at IGC Pharma, down from -$111960.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was -$111960.0 in Q4 2016, with the low at -$1.2 million in Q2 2014.
  • Average Other Operating Expenses over 4 years is -$687939.0, with a median of -$685867.0 recorded in 2016.
  • Peak annual rise in Other Operating Expenses hit 88.75% in 2016, while the deepest fall reached 97.69% in 2016.
  • Over 4 years, Other Operating Expenses stood at -$593845.0 in 2014, then plummeted by 67.64% to -$995502.0 in 2015, then soared by 88.75% to -$111960.0 in 2016, then plummeted by 576.37% to -$757260.0 in 2017.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$757260.0, -$111960.0, and -$614474.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.